a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication

NCT ID: NCT06277414

Last Updated: 2024-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To develop effective preoperative and postoperative prediction models for postoperative complications of ERCP

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To develop effective preoperative and postoperative prediction models for postoperative complications of ERCP based on machine learning

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endoscopic Retrograde Cholangiopancreatography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ERCP

The postoperative laboratory test results, imaging results and symptoms were collected

collection of laboratory test results, imaging results and symptoms

Intervention Type OTHER

collection of laboratory test results, imaging results and symptoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

collection of laboratory test results, imaging results and symptoms

collection of laboratory test results, imaging results and symptoms

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Routine ERCP patients

Exclusion Criteria

* Unwillingness or inability to consent for the study
* Pregnant women or breastfeeding
* current acute pancreatitis
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of University of South China

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of University of South China

Hengyang, Hunan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chen Guodong, PhD

Role: primary

15211450345

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024ll0204001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Percutaneous Cholangiopancreatoscopy Registry
NCT05210322 ACTIVE_NOT_RECRUITING